Published in Microorganisms on June 15, 2016
Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1(+)CD11b(+) myeloid suppressor cells. Oncoimmunology (2017) 0.75
Decreased CD8+CD28+/CD8+CD28- T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease. Medicine (Baltimore) (2017) 0.75
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Human gut microbiome viewed across age and geography. Nature (2012) 19.31
Development of the human infant intestinal microbiota. PLoS Biol (2007) 18.91
Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 18.83
Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol (1977) 17.41
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 15.22
Commensal host-bacterial relationships in the gut. Science (2001) 14.82
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09
Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol (2002) 11.36
Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A (2010) 9.57
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica (1999) 9.04
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol (2007) 6.19
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology (2004) 5.94
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature (2012) 5.63
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe (2007) 5.56
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med (1994) 5.46
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut (2003) 5.19
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02
Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology (2011) 4.88
The application of ecological theory toward an understanding of the human microbiome. Science (2012) 4.69
The indigenous gastrointestinal microflora. Trends Microbiol (1996) 4.51
Crohn's disease. Lancet (2012) 4.42
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology (2002) 4.40
The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med (2011) 4.24
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe (2008) 4.14
Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol (2006) 3.39
Ulcerative colitis. Lancet (2012) 3.38
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut (2011) 3.36
An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol (2008) 3.30
Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell (2013) 3.26
A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem (2007) 3.14
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol (2011) 3.11
Bacterial contributions to mammalian gut development. Trends Microbiol (2004) 3.03
Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol (2006) 3.02
Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun (1999) 2.92
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis (2009) 2.85
Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun (2012) 2.84
Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2013) 2.82
Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr (2000) 2.74
Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genomics (2001) 2.68
Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis (2006) 2.45
The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology (2011) 2.41
Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One (2009) 2.35
High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr (2011) 2.26
Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis (2010) 2.22
Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 2.20
Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol (2011) 2.19
Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr (2010) 2.13
Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol (2008) 2.06
IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol (2012) 2.03
Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med (1987) 2.02
Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res (2007) 1.99
Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol (2002) 1.94
Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.91
Geographical variability and environmental risk factors in inflammatory bowel disease. Gut (2013) 1.84
Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J Proteome Res (2010) 1.84
Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut (2013) 1.83
Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis (2000) 1.77
Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol (2013) 1.75
Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology (2011) 1.70
Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis (2010) 1.70
Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis (2010) 1.69
The role of microbes in Crohn's disease. Clin Infect Dis (2006) 1.65
Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol (2000) 1.64
Serological markers predict inflammatory bowel disease years before the diagnosis. Gut (2012) 1.64
Host-bacterial coevolution and the search for new drug targets. Curr Opin Chem Biol (2008) 1.63
A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biol (2012) 1.62
Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev (2004) 1.61
Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab (2012) 1.55
Family and twin studies in inflammatory bowel disease. World J Gastroenterol (2006) 1.54
Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol (2003) 1.54
Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol (2004) 1.53
Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol (2006) 1.53
Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol (2006) 1.51
Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology (2010) 1.48
The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease. Am J Gastroenterol (2001) 1.48
Is it time for a metagenomic basis of therapeutics? Science (2012) 1.45
Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology (2011) 1.44
A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J (2013) 1.42
Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci (2006) 1.39
Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest (1993) 1.37
Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol (2013) 1.34
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol (2012) 1.31
The human microbiome: ecosystem resilience and health. Nutr Rev (2012) 1.30
Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res (2011) 1.30
Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One (2011) 1.27
Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol (2009) 1.27
Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis (2007) 1.27
The role of infection in the aetiology of inflammatory bowel disease. J Gastroenterol (2010) 1.26
Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy (2011) 1.26
Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol (2007) 1.26